Latest Breaking News On - Wales research ethic committee - Page 1 : comparemela.com

Oxford Cannabinoid Technologies Holdings plc (OCTP), the pharmaceutical company developing prescription cannabinoid medicines, has announced that all cohorts have been dosed in a phase 1 study of OCT461201.

United kingdomClarissa sowemimo cokerValentino parraviciniHealthcare products regulatory agencySimbec researchWales research ethic committeeSimbec orion group ltdEuropean union withdrawalSimbec research limitedTim cornChief medical officerEuropean unionClinical developmentOxford cannabinoid technologies holdingsClinical study